Concepedia

Stephen D. Rubin

SD

15

Publications

8.7K

Citations

15

H-Index

2003

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

AstraZeneca (United States)

The Christie NHS Foundation Trust

Research Triangle Park Foundation

Massachusetts General Hospital

Stephen D. Rubin is an author at GlaxoSmithKline (United States) specializing in medicine, oncology, and obstetrics.

Top concepts

Publications per year

2003–2018

15

Publications

15

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

Charles E. Geyer, John Forster, Deborah Lindquist et al. · New England Journal of Medicine · 2006 · 3.4K citations · Full text

Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib

Caroline Robert, Bogusława Karaszewska, Jacob Schachter et al. · New England Journal of Medicine · 2014 · 2.6K citations · Full text

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

Nancy U. Lin, Véronique Dièras, Devchand Paul et al. · Clinical Cancer Research · 2009 · 656 citations · Full text

A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

Cora N. Sternberg, Robert E. Hawkins, John Wagstaff et al. · European Journal of Cancer · 2013 · 443 citations

, , +5

Gemtuzumab ozogamicin for <i>de novo</i> acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial

Juliette Lambert, Cécile Pautas, Christine Terré et al. · Haematologica · 2018 · 336 citations · Full text

Rows per page

1–5 of 15